Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial - Archive ouverte HAL
Article Dans Une Revue Journal of Critical Care Année : 2023

Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial

Pierre-Yves Meunier
  • Fonction : Auteur
Camille Raynaud
  • Fonction : Auteur
Emmanuelle Guimaraes
  • Fonction : Auteur
Laurent Letrilliart
  • Fonction : Auteur

Résumé

Septic shock is associated in some patients with a profound immunosuppression. We hypothesized that GM-CSF would reduce the occurrence of ICU-acquired infections in immunosuppressed septic patients.

Dates et versions

hal-04726149 , version 1 (08-10-2024)

Identifiants

Citer

Pierre-Yves Meunier, Camille Raynaud, Emmanuelle Guimaraes, François Gueyffier, Laurent Letrilliart. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial. Journal of Critical Care, 2023, 78 (1), pp.154330. ⟨10.1370/afm.2908⟩. ⟨hal-04726149⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More